Risk factors for hyperammonemia in pediatric patients with epilepsy

Epilepsia

Volumn 54, Issue 6, 2013, Pages 983-989

  Yamamoto, Yoshiaki ^a   Takahashi, Yukitoshi ^a   Imai, Katsumi ^a   Mishima, Nobuyuki ^a   Yazawa, Rei ^b   Inoue, Kazuyuki ^b   Itoh, Kunihiko ^b   Kagawa, Yoshiyuki ^b   Inoue, Yushi ^a  

^a SHIZUOKA INSTITUTE OF EPILEPSY AND NEUROLOGICAL DISORDERS   (Japan)

^b UNIVERSITY OF SHIZUOKA   (Japan)

Author keywords

Children; Epilepsy; Hyperammonemia; Phenytoin; Risk factor; Valproic acid

Indexed keywords

ACETAZOLAMIDE; AMMONIA; ETIRACETAM; PHENOBARBITAL; PHENYTOIN; TOPIRAMATE; VALPROIC ACID; ZONISAMIDE;

ADOLESCENT; AMMONIA BLOOD LEVEL; ARTICLE; CHILD; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG USE; EPILEPSY; FEMALE; GENDER; GENERALIZED EPILEPSY; GROUPS BY AGE; HUMAN; HYPERAMMONEMIA; INCIDENCE; INFANT; MAJOR CLINICAL STUDY; MALE; NEWBORN; PRESCHOOL CHILD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR; SCHOOL CHILD; SYMPTOMATIC EPILEPSY;

ACETAZOLAMIDE; ADOLESCENT; AGE FACTORS; ANTICONVULSANTS; CHILD; CHILD, PRESCHOOL; DOSE-RESPONSE RELATIONSHIP, DRUG; EPILEPSY; FEMALE; FRUCTOSE; HUMANS; HYPERAMMONEMIA; INFANT; ISOXAZOLES; MALE; PHENOBARBITAL; PHENYTOIN; RETROSPECTIVE STUDIES; RISK FACTORS; SEX FACTORS; VALPROIC ACID;

EID: 84878577216     PISSN: 00139580     EISSN: 15281167     Source Type: Journal    
DOI: 10.1111/epi.12125     Document Type: Article

References (41)

1. Adams EN, Marks A, Lizer MH,. (2009) Carbamazepine-induced hyperammonemia. Am J Health Syst Pharm 15: 1468-1470.
2. Aires CC, van Cruchten A, Ijlst L, de Almeida IT, Duran M, Wanders RJ, Silva MF,. (2011) New insights on the mechanisms of valproate-induced hyperammonemia: inhibition of hepatic N-acetylglutamate synthase activity by valproyl-Coa. J Hepatol 55: 426-434.
3. Altunbaşak S, Baytok V, Tasouji M, Hergüner O, Burgut R, Kayrin L,. (1997) Asymptomatic hyperammonemia in children treated with valproic acid. J Child Neurol 12: 461-463.
4. Ambrosetto G, Riva R, Baruzzi A,. (1984) Hyperammonemia in asterixis induced by carbamazepine: two case reports. Acta Neurol Scand 69: 186-189.
5. Batshaw ML, Brusilow SW,. (1982) Valproate-induced hyperammonemia. Ann Neurol 11: 319-321.
6. Cagnon L, Braissant O,. (2007) Hyperammonemia-induced toxicity for the developing central nervous system. Brain Res Rev 56: 183-197.
7. Chicharro AV, Kanner AM,. (2007) The measurement of ammonia blood levels in patients taking valproic acid: looking for problems where they do not exist? Epilepsy Behav 11: 361-366.
8. Colombo JP, Peheim E, Kretschmer R, Dauwalder H, Sidiropoulos D,. (1984) Plasma ammonia concentrations in newborns and children. Clin Chim Acta 138: 283-291.
9. Coppola G, Epifanio G, Auricchio G, Federico RR, Resicato G, Pascotto A,. (2006) Plasma free carnitine in epilepsy children, adolescents and young adults treated with old and new antiepileptic drugs with or without ketogenic diet. Brain Dev 28: 358-365.
10. Coulter DL,. (1991) Carnitine, valproate, and toxicity. J Child Neurol 6: 7-14.
11. Coulter DL, Allen RJ,. (1981) Hyperammonemia with valproic acid therapy. J Pediatr 99: 317-319.
12. Deutsch SI, Burket JA, Rosse RB,. (2009) Valproate-induced hyperammonemic encephalopathy and normal liver functions: possible synergism with topiramate. Clin Neuropharmacol 32: 350-352.
13. Galal NM, Fouad HM, Saied A, Dabnon M,. (2010) Hyperammonemia in the pediatric emergency care setting. Pediatr Emerg Care 26: 888-891.
14. Haidukewych D, John G, Zielinski JJ, Rodin EA,. (1985) Chronic valproic acid therapy and incidence of increases in venous plasma ammonia. Ther Drug Monit 7: 290-294.
15. Hamed SA, Abdella MM,. (2009) The risk of asymptomatic hyperammonemia in children with idiopathic epilepsy treated with valproate: relationship to blood carnitine status. Epilepsy Res 86: 32-41.
16. Hamer HM, Knake S, Schomburg U, Rosenow F,. (2000) Valproate-induced hyperammonemic encephalopathy in the presence of topiramate. Neurology 54: 230-232.
17. Hug G, McGraw CA, Bates SR, Landrigan EA,. (1991) Reduction of serum carnitine concentrations during anticonvulsant therapy with phenobarbital, valproic acid, phenytoin, and carbamazepine in children. J Pediatr 119: 799-802.
18. Hung TY, Chen CC, Wang TL, Su CF, Wang RF,. (2011) Transient hyperammonemia in seizures: a prospective study. Epilepsia 52: 2043-2049.
19. Iinuma K, Hayasaka K, Narisawa K, Tada K, Hori K,. (1988) Hyperamino-acidaemia and hyperammonaemia in epileptic children treated with valproic acid. Eur J Pediatr 148: 267-269.
20. Katano H, Fukushima T, Karasawa K, Sugiyama N, Ohkura A, Kamiya K,. (2002) Primidone-induced hyperammonemic encephalopathy in a patient with cerebral astrocytoma. J Clin Neurosci 9: 79-81.
21. Kim JM, Ryu WS, Hwang YH, Kim JS,. (2007) Aggravation of ataxia due to acetazolamide induced hyperammonaemia in episodic ataxia. J Neurol Neurosurg Psychiatry 78: 771-772.
22. Knudsen JF, Sokol GH, Flowers CM,. (2008) Adjunctive topiramate enhances the risk of hypothermia associated with valproic acid therapy. J Clin Pharm Ther 33: 513-519.
23. Kondo T, Ishida M, Kaneko S, Hirano T, Otani K, Fukushima Y, Muranaka H, Koide N, Yokoyama M, Nakata S,. (1992) Is 2-propyl-4-pentenoic acid, a hepatotoxic metabolite of valproate, responsible for valproate-induced hyperammonemia? Epilepsia 33: 550-554.
24. Labib PL, Wing S, Bhowmik A,. (2011) Transient hyperammonaemia in a patient with confusion: challenges with the differential diagnosis. BMJ Case Rep Sep 4 [Epub ahead of print].
25. Laub MC,. (1986) Nutritional influence on serum ammonia in young patients receiving sodium valproate. Epilepsia 27: 55-59.
26. Lichter-Konecki U,. (2008) Profiling of astrocyte properties in the hyperammonaemic brain: shedding new light on the pathophysiology of the brain damage in hyperammonaemia. J Inherit Metab Dis 31: 492-502.
27. Liu KT, Su CS,. (2008) Postictal transient hyperammonemia. Am J Emerg Med 26 (388): e1-e2.
28. Liu KT, Yang SC, Yeh IJ, Lin TJ, Lee CW,. (2011) Transient hyperammonemia associated with postictal state in generalized convulsion. Kaohsiung J Med Sci 27: 453-456.
29. Longin E, Teich M, Koelfen W, König S,. (2002) Topiramate enhances the risk of valproate-associated side effects in three children. Epilepsia 43: 451-454.
30. Murphy JV, Marquardt K,. (1982) Asymptomatic hyperammonemia in patients receiving valproic acid. Arch Neurol 39: 591-592.
31. Mutch BJ, Banister EW,. (1983) Ammonia metabolism in exercise and fatigue: a review. Med Sci Sports Exerc 15: 41-50.
32. Nakajima Y, Ito T, Maeda Y, Ichiki S, Kobayashi S, Ando N, Hussein MH, Kurono Y, Sugiyama N, Togari H,. (2011) Evaluation of valproate effects on acylcarnitine in epileptic children by LC-MS/MS. Brain Dev 33: 816-823.
33. Ohtani Y, Endo F, Matsuda I,. (1982) Carnitine deficiency and hyperammonemia associated with valproic acid therapy. J Pediatr 101: 782-785.
34. Pleym H, Spigset O, Kharasch ED, Dale O,. (2003) Gender differences in drug effects: implications for anesthesiologists. Acta Anaesthesiol Scand 47: 241-259.
35. Sharma S, Gulati S, Kabra M, Kalra V, Vasisht S, Gupta YK,. (2011) Blood ammonia levels in epileptic children on 2 dose ranges of valproic acid monotherapy: a cross-sectional study. J Child Neurol 26: 109-112.
36. Thom H, Carter PE, Cole GF, Stevenson KL,. (1991) Ammonia and carnitine concentrations in children treated with sodium valproate compared with other anticonvulsant drugs. Dev Med Child Neurol 33: 795-802.
37. Verbiest HB, Straver JS, Colombo JP, van der Vijver JC, van Woerkom TC,. (1992) Carbamyl phosphate synthetase-1 deficiency discovered after valproic acid-induced coma. Acta Neurol Scand 86: 275-279.
38. Verrotti A, Greco R, Morgese G, Chiarelli F,. (1999) Carnitine deficiency and hyperammonemia in children receiving valproic acid with and without other anticonvulsant drugs. Int J Clin Lab Res 29: 36-40.
39. Wilkinson DJ, Smeeton NJ, Watt PW,. (2010) Ammonia metabolism, the brain and fatigue; revisiting the link. Prog Neurobiol 91: 200-219.
40. Yamamoto Y, Takahashi Y, Suzuki E, Mishima N, Inoue K, Itoh K, Kagawa Y, Inoue Y,. (2012) Risk factors for hyperammonemia associated with valproic acid therapy in adult epilepsy patients. Epilepsy Res 101: 202-209.
41. Yanagawa Y, Nishi K, Sakamoto T,. (2008) Hyperammonemia is associated with generalized convulsion. Intern Med 47: 21-23.